Retina

Study shows routine use may improve patient management, guide procedure planning

Tool is empowering patients to understand disease, become more involved in their treatment.

Visual cortical prosthesis intended to create artificial form of useful vision for blind individuals

Dr. Kaiser discusses how risuteganib fared in a phase II trial in patients with intermediate nonexudative AMD. 

ICYMI: Dr. Blinder compares the efficiencies between two surgical cutters

Eyes with persistent subretinal fluid fared better with visual acuity than eyes that were dry, according to the HARBOR Trial

Uveitic glaucoma presents a treatment challenge because of the need to control two conditions. Furthermore, side effects of conventional treatments for uveitis-corticosteroids and systemic immunomodulatory agents-limit their use.

Sixty-five genes identified with several belonging to signaling pathways

Amid the introduction of new technologies, device still playing critical role

Anatomic changes after RD might help determine best time for surgery

May provide better anatomic improvement, decreased DR severity scores

Ganglion, bipolar cells increase options for patients with late-stage retinal disease

The probability of non-ocular malignancies differs between men, women

Study compares preoperative risk factors, co-pathology in patients

Research offers guidance on NSAID use, identifies etiologic role of abnormal IOP

Imaging provides ophthalmologists with additional valuable information

With imaging artifacts common, clinicians must be focused on key points

Technology makes great tool, requires extra vigilance with co-existing disease

Quick visual recovery is important for this young population

Physicians also can focus on treating inflammation and IOP in patients